Magazine

Inside: Life after Goldilocks – six insiders analyze the new economic climate; TPG debuts GP-led secondaries fund; The dangers posed by capital call loans; A secondaries roundtable; Plus much more…

Inside: Celebrating 21 years of Private Equity International; How the asset class has been transformed; Profiles of 21 changemakers who put their stamp on the industry; Expert comment and analysis; Plus much more…

Inside: Private equity’s macro headache – how GPs are arming themselves against macro uncertainty; Emerging markets – a nine-page special report; A European mid-market roundtable; Plus much more…

Inside: After years of seemingly unstoppable growth are LPs about the breaks on private equity investment? Our annual survey of how investors see the year ahead answers your questions; Plus expert comment and analysis from industry leaders and much more…

Inside: Going green with envy – why investors are moving back to oil and gas; Carlyle’s bellwether tender offer; It’s a dog-eat-dogfood world as firms fight for space in the pets market; Orlando Bravo on tech investing; Plus much more…

Inside: How technology investors are fighting back against public market disruption; Why are buyouts firms undeterred by the tech downturn? Keynote interviews with Vista Equity Partners and BC Partners; Plus much more…

Inside: A deep dive into Waterland, Europe’s buy-and-build machine; An 11-page debt finance special report; Keynote interviews with 17Capital and EY; How private equity is moving into sports ownership; Plus much more…

Inside: Creating momentum – how private equity is putting its impact capital to work; A deep dive into six impact themes; Keynote interviews and expert analysis from industry leaders; Plus much more…

In the magazine: How private equity is joining the big leagues of pro sports; ESG clouds in the Sunshine state; The fundraising prospects for 2023; Plus much more…

In the magazine: Why co-investors are bullish about opportunities; Profiles of 10 leading LPs targeting co-investments; Keynote interviews with Northleaf Capital Partners, Manulife Investment Management; Plus much more…